{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:40:18Z","timestamp":1776703218071,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"DOI":"10.1007\/s00117-026-01609-3","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:43:15Z","timestamp":1776699795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroimaging features of EBV-associated primary central nervous system lymphoproliferative disorder in HIV-positive individuals","Befunde in der Neurobildgebung des EBV-bedingten prim\u00e4ren lymphoproliferativen Syndroms im zentralen Nervensystem bei HIV-positiven Personen"],"prefix":"10.1007","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Shuang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Ming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"1609_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio\u00a0R, Amador\u00a0C, Anagnostopoulos\u00a0I, Attygalle\u00a0AD, Araujo\u00a0I, Berti\u00a0E et\u00a0al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"1609_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/jop.13204","volume":"50","author":"L Robinson","year":"2021","unstructured":"Robinson\u00a0L, Fonseca\u00a0FP, van Heerden\u00a0W (2021) Benign lymphoproliferative disorders in the immunosuppressed patient: an update. J\u00a0Oral Pathol Med 50:540\u2013547","journal-title":"J Oral Pathol Med"},{"key":"1609_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.semdp.2012.08.006","volume":"30","author":"A Chadburn","year":"2013","unstructured":"Chadburn\u00a0A (2013) Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV\/HHV8). Semin Diagn Pathol 30:113\u2013129","journal-title":"Semin Diagn Pathol"},{"key":"1609_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","volume":"102","author":"SK Dunmire","year":"2018","unstructured":"Dunmire\u00a0SK, Verghese\u00a0PS, Balfour\u00a0HJ (2018) Primary Epstein-Barr virus infection. J\u00a0Clin Virol 102:84\u201392","journal-title":"J Clin Virol"},{"key":"1609_CR5","doi-asserted-by":"crossref","unstructured":"Andrei G, Trompet E, Snoeck R (2019) Novel Therapeutics for Epstein(-)Barr Virus. Molecules 24.","DOI":"10.3390\/molecules24050997"},{"key":"1609_CR6","doi-asserted-by":"crossref","unstructured":"Dojcinov SD, Fend F, Quintanilla-Martinez L (2018) EBV-Positive Lymphoproliferations of B\u2011 T\u2011 and NK-Cell Derivation in Non-Immunocompromised Hosts. Pathogens 7.","DOI":"10.3390\/pathogens7010028"},{"key":"1609_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01723","volume":"10","author":"P Shindiapina","year":"2020","unstructured":"Shindiapina\u00a0P, Ahmed\u00a0EH, Mozhenkova\u00a0A, Abebe\u00a0T, Baiocchi\u00a0RA (2020) Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals. Front Oncol 10:1723","journal-title":"Front Oncol"},{"key":"1609_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","volume":"482","author":"L Quintanilla-Martinez","year":"2023","unstructured":"Quintanilla-Martinez\u00a0L, Swerdlow\u00a0SH, Tousseyn\u00a0T, Barrionuevo\u00a0C, Nakamura\u00a0S, Jaffe\u00a0ES (2023) New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Arch 482:227\u2013244","journal-title":"Virchows Arch"},{"key":"1609_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040096","volume":"4","author":"O Gasser","year":"2007","unstructured":"Gasser\u00a0O, Bihl\u00a0FK, Wolbers\u00a0M, Loggi\u00a0E, Steffen\u00a0I, Hirsch\u00a0HH et\u00a0al (2007) HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. PLoS medicine 4:e96","journal-title":"PLoS medicine"},{"key":"1609_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-02078-z","volume":"20","author":"Z Wan","year":"2023","unstructured":"Wan\u00a0Z, Chen\u00a0Y, Hui\u00a0J, Guo\u00a0Y, Peng\u00a0X, Wang\u00a0M et\u00a0al (2023) Epstein-Barr virus variation in people living with human immunodeficiency virus in southeastern China. Virology journal 20:107","journal-title":"Virology journal"},{"key":"1609_CR11","first-page":"775","volume":"9","author":"K Wang","year":"2022","unstructured":"Wang\u00a0K, Li\u00a0J, Zhou\u00a0X, Lv\u00a0J, Wang\u00a0Y, Li\u00a0X (2022) Case Report: Primary Indolent Epstein-Barr Virus-Positive T\u2011Cell Lymphoproliferative Disease Involving the Central Nervous System. Front Surg 9:775\u2013185","journal-title":"Front Surg"},{"key":"1609_CR12","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson\u00a0DA, Gross\u00a0A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N\u00a0Engl J Med 350:1328\u20131337","journal-title":"N Engl J Med"},{"key":"1609_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41408-022-00630-8","volume":"12","author":"A Berhan","year":"2022","unstructured":"Berhan\u00a0A, Bayleyegn\u00a0B, Getaneh\u00a0Z (2022) HIV\/AIDS Associated Lymphoma: Review. Blood Lymphat Cancer 12:31\u201345","journal-title":"Blood Lymphat Cancer"},{"key":"1609_CR14","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.20160248","volume":"213","author":"T Tagawa","year":"2016","unstructured":"Tagawa\u00a0T, Albanese\u00a0M, Bouvet\u00a0M, Moosmann\u00a0A, Mautner\u00a0J, Heissmeyer\u00a0V et\u00a0al (2016) Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J\u00a0Exp Med 213:2065\u20132080","journal-title":"J Exp Med"},{"key":"1609_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01723","volume":"10","author":"P Shindiapina","year":"2020","unstructured":"Shindiapina\u00a0P, Ahmed\u00a0EH, Mozhenkova\u00a0A, Abebe\u00a0T, Baiocchi\u00a0RA (2020) Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals. Front Oncol 10:1723","journal-title":"Front Oncol"},{"key":"1609_CR16","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1182\/blood-2006-04-016923","volume":"108","author":"HJ Epple","year":"2006","unstructured":"Epple\u00a0HJ, Loddenkemper\u00a0C, Kunkel\u00a0D, Troger\u00a0H, Maul\u00a0J, Moos\u00a0V et\u00a0al (2006) Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108:3072\u20133078","journal-title":"Blood"},{"key":"1609_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00734","volume":"9","author":"AJ Kleinman","year":"2018","unstructured":"Kleinman\u00a0AJ, Sivanandham\u00a0R, Pandrea\u00a0I, Chougnet\u00a0CA, Apetrei\u00a0C (2018) Regulatory T Cells As Potential Targets for HIV Cure Research. Front Immunol 9:734","journal-title":"Front Immunol"},{"key":"1609_CR18","first-page":"149","volume":"138","author":"SJ Hamilton-Dutoit","year":"1991","unstructured":"Hamilton-Dutoit\u00a0SJ, Pallesen\u00a0G, Franzmann\u00a0MB, Karkov\u00a0J, Black\u00a0F, Skinhoj\u00a0P et\u00a0al (1991) AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 138:149\u2013163","journal-title":"Am J Pathol"},{"key":"1609_CR19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2214\/ajr.172.4.10587158","volume":"172","author":"PJ Pickhardt","year":"1999","unstructured":"Pickhardt\u00a0PJ, Wippold\u00a0FN (1999) Neuroimaging in posttransplantation lymphoproliferative disorder. AJR Am J Roentgenol 172:1117\u20131121","journal-title":"AJR Am J Roentgenol"},{"key":"1609_CR20","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.radcr.2024.02.030","volume":"19","author":"D Hoyt","year":"2024","unstructured":"Hoyt\u00a0D, Hughes\u00a0J, Liu\u00a0J, Ayyad\u00a0H (2024) Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings. Radiol Case Rep 19:2168\u20132182","journal-title":"Radiol Case Rep"},{"key":"1609_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-024-01605-y","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang\u00a0X, Deng\u00a0X, Wu\u00a0M, Chen\u00a0SW, Jiang\u00a0M, Long\u00a0L et\u00a0al (2024) Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with beta-thalassemia: a case series and review of literature. Insights Imaging 15:40","journal-title":"Insights Imaging"},{"key":"1609_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1309\/N82CTQ1J0XEVEFQB","volume":"121","author":"AA Castellano-Sanchez","year":"2004","unstructured":"Castellano-Sanchez\u00a0AA, Li\u00a0S, Qian\u00a0J, Lagoo\u00a0A, Weir\u00a0E, Brat\u00a0DJ (2004) Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121:246\u2013253","journal-title":"Am J Clin Pathol"},{"key":"1609_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0726-6","volume":"10","author":"ML White","year":"2019","unstructured":"White\u00a0ML, Moore\u00a0DW, Zhang\u00a0Y, Mark\u00a0KD, Greiner\u00a0TC, Bierman\u00a0PJ (2019) Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential. Insights Imaging 10:46","journal-title":"Insights Imaging"},{"key":"1609_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.12659\/AOT.890372","volume":"19","author":"J Bocian","year":"2014","unstructured":"Bocian\u00a0J, Januszkiewicz-Lewandowska\u00a0D (2014) Utility of quantitative EBV DNA measurements in cerebrospinal fluid for diagnosis and monitoring of treatment of central nervous system EBV-associated post-transplant lymphoproliferative disorder after allogenic hematopoietic stem cell transplantation. Ann Transplant 19:253\u2013256","journal-title":"Ann Transplant"},{"key":"1609_CR25","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose\u00a0J, Armitage\u00a0J, Weisenburger\u00a0D (2008) International peripheral T\u2011cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J\u00a0Clin Oncol 26:4124\u20134130","journal-title":"J Clin Oncol"},{"key":"1609_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","volume":"13","author":"A Carbone","year":"2008","unstructured":"Carbone\u00a0A, Gloghini\u00a0A, Dotti\u00a0G (2008) EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 13:577\u2013585","journal-title":"Oncologist"},{"key":"1609_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00043426-199901000-00009","volume":"21","author":"S Ohga","year":"1999","unstructured":"Ohga\u00a0S, Takada\u00a0H, Honda\u00a0K, Inamura\u00a0T, Gondo\u00a0K, Ohshima\u00a0K et\u00a0al (1999) Central nervous system T\u2011cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection. J\u00a0Pediatr Hematol Oncol 21:42\u201346","journal-title":"J Pediatr Hematol Oncol"},{"key":"1609_CR28","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren\u00a0O, Gilbert\u00a0ES, Rizzo\u00a0JD, Socie\u00a0G, Banks\u00a0PM, Sobocinski\u00a0KA et\u00a0al (2009) Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 113:4992\u20135001","journal-title":"Blood"},{"key":"1609_CR29","first-page":"169","volume":"10","author":"R Tadipatri","year":"2023","unstructured":"Tadipatri\u00a0R, Ekhator\u00a0C, Narayan\u00a0R, Azadi\u00a0A, Yuen\u00a0K, Grewal\u00a0J et\u00a0al (2023) Iatrogenic immunodeficiency-associated lymphoproliferative disorders of the central nervous system: a treatment paradox. Neurooncol Pract 10:169\u2013175","journal-title":"Neurooncol Pract"},{"key":"1609_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114797","volume":"163","author":"H He","year":"2023","unstructured":"He\u00a0H, Lei\u00a0F, Huang\u00a0L, Wang\u00a0K, Yang\u00a0Y, Chen\u00a0L et\u00a0al (2023) Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350\/CD89-targeted bispecific antibody. Biomed Pharmacother 163:114797","journal-title":"Biomed Pharmacother"}],"container-title":["Die Radiologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-026-01609-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-026-01609-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-026-01609-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:43:19Z","timestamp":1776699799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-026-01609-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":30,"alternative-id":["1609"],"URL":"https:\/\/doi.org\/10.1007\/s00117-026-01609-3","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"value":"2731-7048","type":"print"},{"value":"2731-7056","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H.\u00a0Chen, C.-S.\u00a0Guan, R.-M.\u00a0Xie, J.-M.\u00a0Chen, B.\u00a0Liang and J.-J.\u00a0Li declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (in its most recently amended version). Informed consent was obtained from all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}